Hugo Fernandez

7PUBLICATIONS
40CO-AUTHORS
Gene and molecular therapyMedical infection agents (incl. prions)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 24, 2026
Posttransplant MRD monitoring by TP53 duplex sequencing with APR-246 + azacitidine maintenance predicts outcomes.

David A Sallman, Amy F McLemore, Rami Komrokji

|Nov 25, 2025
Posttransplant MRD monitoring by TP53 duplex sequencing with APR-246 + azacitidine maintenance predicts outcomes.

David A Sallman, Amy F McLemore, Rami Komrokji

|Dec 29, 2022
DNA polymerase θ protects leukemia cells from metabolically induced DNA damage.

Umeshkumar Vekariya, Monika Toma, Margaret Nieborowska-Skorska

|Jul 11, 2022
Eprenetapopt Plus Azacitidine After Allogeneic Hematopoietic Stem-Cell Transplantation for TP53-Mutant Acute Myeloid Leukemia and Myelodysplastic Syndromes.

Asmita Mishra, Roni Tamari, Amy E DeZern

|Oct 14, 2021
A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease.

Aleksandr Lazaryan, Stephanie Lee, Mukta Arora

Pageof 2